IRCT201704246712N3已完成3 期
Comparison of the Efficacy of Sitagliptin with Pioglitazone on the Control of Diabetic Patients
Vice Chancellor for Research of Tabriz University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 65 years（—）
- 性别
- All
入选标准
- •Diabetics Type II; taking complete doze of Metformin (1500-2000mg) and a Sulfonylurea (15-20mg); age range from 30 to 65; 7% = HbAlc; Reluctance to take insulin; willingness to participate in the study. Exclusion criteria: pregnant patient; patients with heart failure; patients with renal insufficiency; patients with bladder cancer background; Glycemic severe complications including DKA; Reluctance to participate in the study.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Sitagliptin and Pioglitazon effects in the treatment of diabetesIRCT2015061619554N4Vice chancellor for research; Zanjan University of Medical Sciences160
已完成
不适用
Efficacy and Safety comparison of Sitagliptin and Glimepiride in elderly Japanese patients with type 2 diabetestype 2 diabetesJPRN-UMIN000004047Japan Association for Diabetes Education and Care900
已完成
不适用
Comparison of efficacy and safety of sitagliptin or ipragliflozin in type 2 diabetic patients with insulin therapyType 2 diabetesJPRN-UMIN000014139Yokohama City University70
尚未招募
4 期
A clinical study to understand the combined effects ofSitagliptin & metformin, in comparison to Glimepiride & metformin treatment in type 2 diabetes patientsCTRI/2024/04/065877Dr Keerthi Rajan M
已完成
不适用
Comparison of effectiveness of sitagliptin and nateglinide in type 2 diabetes.type 2 diabetesJPRN-UMIN000006278Japanese Red Cross Medical Center40